Literature DB >> 34244237

Interventional Optical Imaging Permits Instant Visualization of Pathological Zones of Ablated Tumor Periphery and Residual Tumor Detection.

Xuefeng Kan1,2, Guanhui Zhou1,3, Feng Zhang1, Hongxiu Ji1, Hui Zheng1,4, Jeffrey Forris Beecham Chick1, Karim Valji1, Chuansheng Zheng2, Xiaoming Yang5.   

Abstract

Optical imaging (OI) provides real-time clinical imaging capability and simultaneous molecular, morphological, and functional information of disease processes. In this study, we present a new interventional OI technique, which enables in vivo visualization of three distinct pathologic zones of ablated tumor periphery for immediate detection of residual tumors during a radiofrequency ablation (RFA) session. Rabbits with orthotopic hepatic tumors were divided into two groups (n = 8/group): incomplete RFA and complete RFA. Indocyanine green-based interventional OI was used to differentiate three pathological zones: ablated tumor, transition margin, and residual tumor or surrounding normal liver-with quantitative comparison of signal-to-background ratios among the three zones and between incompletely and completely ablated tumors. Subsequent ex vivo OI and pathologic correlation were performed to confirm the findings of interventional OI. Interventional OI could differentiate incompletely or completely ablated tumor peripheries, thus permitting identification of residual tumor. This technique may open new avenues for immediate assessment of tumor eradication during a single interventional ablation session. SIGNIFICANCE: Interventional optical imaging can instantly visualize pathologic zones of ablated tumor peripheries to detect residual tumors, which could revolutionize current image-guided interventional oncologic ablation techniques. ©2021 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34244237      PMCID: PMC8416943          DOI: 10.1158/0008-5472.CAN-21-1040

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  34 in total

1.  Shortwave infrared fluorescence imaging with the clinically approved near-infrared dye indocyanine green.

Authors:  Jessica A Carr; Daniel Franke; Justin R Caram; Collin F Perkinson; Mari Saif; Vasileios Askoxylakis; Meenal Datta; Dai Fukumura; Rakesh K Jain; Moungi G Bawendi; Oliver T Bruns
Journal:  Proc Natl Acad Sci U S A       Date:  2018-04-06       Impact factor: 11.205

2.  Real-time Navigation for Liver Surgery Using Projection Mapping With Indocyanine Green Fluorescence: Development of the Novel Medical Imaging Projection System.

Authors:  Hiroto Nishino; Etsuro Hatano; Satoru Seo; Takashi Nitta; Tomoyuki Saito; Masaaki Nakamura; Kayo Hattori; Muneo Takatani; Hiroaki Fuji; Kojiro Taura; Shinji Uemoto
Journal:  Ann Surg       Date:  2018-06       Impact factor: 12.969

3.  Early PET/CT after radiofrequency ablation in colorectal cancer liver metastases: is it useful?

Authors:  Zhao-Yu Liu; Zhi-Hui Chang; Zai-Ming Lu; Qi-Yong Guo
Journal:  Chin Med J (Engl)       Date:  2010-07       Impact factor: 2.628

Review 4.  Percutaneous ablation of hepatocellular carcinoma: current status.

Authors:  Justin P McWilliams; Shota Yamamoto; Steven S Raman; Christopher T Loh; Edward W Lee; David M Liu; Stephen T Kee
Journal:  J Vasc Interv Radiol       Date:  2010-08       Impact factor: 3.464

Review 5.  Hepatocellular carcinoma treated with radio-frequency ablation: spectrum of imaging findings.

Authors:  Seung Kwon Kim; Hyo Keun Lim; Young Han Kim; Won Jae Lee; Soon Jin Lee; Seung Hoon Kim; Jae Hoon Lim; Soo Ah Kim
Journal:  Radiographics       Date:  2003 Jan-Feb       Impact factor: 5.333

6.  Results of liver resection in combination with radiofrequency ablation for hepatic malignancies.

Authors:  R M Eisele; J Zhukowa; S Chopra; S C Schmidt; U Neumann; J Pratschke; G Schumacher
Journal:  Eur J Surg Oncol       Date:  2009-09-01       Impact factor: 4.424

7.  Quantitative fluorescence angiography detects dynamic changes in gastric perfusion.

Authors:  Jens Osterkamp; Rune Strandby; Nikolaj Nerup; Morten Svendsen; Lars Svendsen; Michael Achiam
Journal:  Surg Endosc       Date:  2020-11-30       Impact factor: 4.584

8.  Combined ultrasound/computed tomography guidance in percutaneous radiofrequency ablation after transarterial chemoembolization for hepatocellular carcinoma in the hepatic dome.

Authors:  Xuefeng Kan; Yong Wang; Bin Xiong; Chuansheng Zheng; Ping Han; Qi Yao; Kun Qian
Journal:  Cancer Manag Res       Date:  2019-08-15       Impact factor: 3.989

9.  Safety margin assessment after microwave ablation of liver tumors: inter- and intrareader variability.

Authors:  Jan Schaible; Benedikt Pregler; Wolf Bäumler; Ingo Einspieler; Ernst-Michael Jung; Christian Stroszczynski; Lukas Philipp Beyer
Journal:  Radiol Oncol       Date:  2020-02-12       Impact factor: 2.991

10.  Combination of percutaneous radiofrequency ablation and systemic chemotherapy are effective treatment modalities for metachronous liver metastases from gastric cancer.

Authors:  Jun-Eul Hwang; Seung-Hun Kim; Joon Jin; Ji-Yun Hong; Min-Jee Kim; Sung-Hoon Jung; Hyun-Jeong Shim; Woo-kyun Bae; Eu-Chang Hwang; Jin-Woong Kim; Sang-Soo Shin; Oh Jeong; Young Kyu Park; Sang-Hee Cho; Ik-Joo Chung
Journal:  Clin Exp Metastasis       Date:  2013-08-22       Impact factor: 5.150

View more
  3 in total

1.  Superpixel spectral unmixing framework for the volumetric assessment of tissue chromophores: A photoacoustic data-driven approach.

Authors:  Valeria Grasso; Regine Willumeit-Rӧmer; Jithin Jose
Journal:  Photoacoustics       Date:  2022-05-11

2.  Interventional Optical Imaging-Monitored Synergistic Effect of Radio-Frequency Hyperthermia and Oncolytic Immunotherapy.

Authors:  Hui Zheng; Feng Zhang; Wayne Monsky; Hongxiu Ji; Weizhu Yang; Xiaoming Yang
Journal:  Front Oncol       Date:  2022-01-24       Impact factor: 6.244

3.  Development of a Three-Dimensional Multi-Modal Perfusion-Thermal Electrode System for Complete Tumor Eradication.

Authors:  Hui Zheng; Peicheng Li; Ruidong Ma; Feng Zhang; Hongxiu Ji; Wayne L Monsky; Evan Johnson; Weizhu Yang; Caifang Ni; Dayong Gao; Xiaoming Yang
Journal:  Cancers (Basel)       Date:  2022-09-29       Impact factor: 6.575

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.